Introduction Why Reimbursement Analysis Fails to Give You an Accurate Picture of MedTech Funding In every DRG-based health system — whether Germany’s G-DRG, France’s GHS, the UK’s NHS Payment Scheme, …
Odelle Technology
-
-
This article reviews the most important biotech news this week, highlighting the breakthrough approval of Bayer’s non-hormonal menopause drug Lynkuet and the major clinical failure faced by Alector in frontotemporal …
-
Why KVÅ Procedure Reimbursement Matters in Sweden KVÅ procedure reimbursement is one of the most powerful—but often misunderstood—mechanisms in the Swedish healthcare system. What appears to be a simple six-character …
-
France has entered a new, more disciplined era in the governance of diagnostic innovation—an era in which public funding is tied directly to evidence, real-world performance, and measurable system-level value, …
-
How HRGs, tariffs, OPCS coding and clinical data science quietly determine how UK hospitals are funded and why this machinery shapes every diagnosis, procedure and financial decision across the NHS. …
-
Executive Summary: Conditional Reimbursement and Evidence-Linked Market Access Across Europe Europe’s healthcare systems are entering a new phase where biotech, pharmaceutical, MedTech, and digital innovations are funded not simply for …
-
How Germany’s Reimbursement System Evaluates Evidence and Cost Why the G-BA Matters In Germany, reimbursement decisions begin and end with the Gemeinsamer Bundesausschuss (G-BA) — the Federal Joint Committee responsible …
-
News
The NHS 10-Year Plan Paradox: How to author creative reimbursement. How Innovation Risks Becoming a Bottleneck in a Decade of “Transformation”
The Promise and the Paradox The UK Government’s 10-Year Health Plan for England (2025–2035) presents itself as a blueprint for a modernised NHS—one that is digitally enabled, outcomes-measured, genomically informed, …
-
Beginning in 2026, PMCF stops being a compliance afterthought and becomes the single biggest determinant of CE-mark renewal.Notified Bodies (NBs) are raising scientific standards, CORE-MD has formalised acceptable methodologies, and …
-
News
How to get paid for digital therapies, including codes for billing, remote patient monitoring, telehealth, AI, and 2026 Digital Therapeutics Billing: CPT, HCPCS, RPM/RTM, AI
2025 Guide to Digital Therapeutics Reimbursement (CPT®, HCPCS, AI, CMS/AMA) The document includes verified CPT® and HCPCS codes, AI Category III routes, real-world case studies, state and federal policy signals, …